Regina Raab
Neurology · Lexington, KYNPI 1851443378
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $845 and has fallen 90.1% since, to $84 in 2023. That places this record below the midpoint for neurology clinicians in KY, where the typical reported total is $1,714.
Across 107 payments — averaging $14.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$353
- Biohaven Pharmaceutical Holding Company Ltd.$203
- Biohaven Pharmaceuticals, Inc.$154
- Harmony Biosciences LLC$98
- Amgen$88
- SK Life Science, Inc.$87
- plus $551 from 11 others
What the payments were for
- Food & beverage$1,47896%
- Education$564%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,534 in reported general payments places this provider in the 45th percentile of 210 neurology providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rivastigmine | 14 | $3,305 |
| Memantine Hcl | 65 | $1,454 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 31 | $706 |
| Sumatriptan Succinate | 11 | $706 |
| Donepezil Hcl | 54 | $434 |
| Levetiracetam | 11 | $345 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 16 | $212 |
| Trazodone Hcl | 15 | $194 |
| Duloxetine Hcl | 12 | $187 |
| Gabapentin | 17 | $182 |
| AmantadineAmantadine Hcl | 11 | $160 |
| Topiramate | 12 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Upsher-smith Laboratories LLCTopiramate | $52 | $5912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 210 neurology providers in Kentucky.
Other neurology in Lexington
- James WinkleyLexington$807K
- Nicole EvermanLexington$355K
- Toufic FakhouryLexington$278K
- Fred OdagoLexington$28K
- Zabeen MahuwalaLexington$28K
- Jagannadha AvasaralaLexington$15K
- Joshua ChalkleyLexington$15K
- Brian PlatoLouisville$232K
- Kristi NordLouisville$217K
- Naveed AhmedPikeville$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.